Glucagon Receptor Protein-VLP (GCGR)
-
- 抗原 See all Glucagon Receptor (GCGR) 蛋白
- Glucagon Receptor (GCGR)
- 蛋白类型
- VLP
-
宿主
- 人
-
资源
- HEK-293 Cells
- 原理
- Human GCGR / Glucagon receptor Full Length Protein (VLP)
- 序列
- Ala 26 - Asn 432
- 产品特性
- Human GCGR Full Length Protein (VLP) is expressed from human 293 cells (HEK293). It contains AA Ala 26 - Asn 432 (Accession # P47871-1).
- 内毒素水平
- 1.0 EU per μg
- Top Product
- Discover our top product GCGR 蛋白
-
Glucagon Receptor (GCGR) (AA 26-136) protein (His tag)
Crystallography grade GCGR 宿主: 人 宿主: Insect Cells Recombinant >95 % as determined by SDS PAGE, Size Exclusion Chromatography and Western Blot. Crys, ELISA, SDS, WB
Glucagon Receptor (GCGR) (AA 27-137) protein (His tag)Crystallography grade GCGR 宿主: 小鼠 宿主: Insect Cells Recombinant >95 % as determined by SDS PAGE, Size Exclusion Chromatography and Western Blot. Crys, ELISA, SDS, WB
Glucagon Receptor (GCGR) (AA 26-477) protein (rho-1D4 tag)Crystallography grade GCGR 宿主: 人 宿主: Insect Cells Recombinant >95 % as determined by SDS PAGE, Size Exclusion Chromatography and Western Blot. Crys, ELISA, SDS, WB
Glucagon Receptor (GCGR) (AA 27-485) protein (rho-1D4 tag)Crystallography grade GCGR 宿主: 小鼠 宿主: Insect Cells Recombinant >95 % as determined by SDS PAGE, Size Exclusion Chromatography and Western Blot. Crys, ELISA, SDS, WB
Glucagon Receptor (GCGR) (AA 26-136) protein (His tag)GCGR 宿主: 人 宿主: HEK-293 Cells Recombinant >90 % as determined by SDS-PAGE.
-
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- PBS, Arginine, pH 7.4
- 储存条件
- -80 °C
- 储存方法
- -70°C
-
- 抗原
- Glucagon Receptor (GCGR)
- 别名
- GCGR (GCGR 产品)
- 别名
- GCGR Protein, GGR Protein, GR Protein, glucagon receptor Protein, GCGR Protein, Gcgr Protein
- 背景
- The protein encoded by this gene is a glucagon receptor that is important in controlling blood glucose levels. Defects in this gene are a cause of type 2 diabetes mellitus (T2DM) . The ever increasing prevalence of type 2 diabetes mellitus in the developed and developing nations calls for the introduction of new and more effective treatments. Glucagon receptor (GCGR) antagonists are highly validated in preclinical models of T2DM and thus have the potential to be developed as a new therapy.
- 途径
- Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
-
